Description | TheBiosensisAG-400-AGkitutilizesanethidiumbromidecounterstainforaquickandeffectivewaytovisualizecellnucleiandcellbodiesofcellswhileunderUVIlluminationallowingtheassessmentofamyloidplaquesandcell/tissuepositioningaswellinonestep. Amylo-Glo®RTDReadytoDiluteStainingreagentisdesignedtostainamyloidplaquesintissuesections.ThisnovelMarkerhasseveraladvantagesoverotherconventionalmarkerssuchasThioflavinSandCongoRedbecauseofitsuniquechemicalandspectralproperties.(L.Schmuedetal.(2012)J.NeuroscienceMethods209:120126). UsingAmylo-Glo®resultsinaverybrightblueUVexcitablestainunderphysiologicalconditionsthatwillnotbleedthroughwhenilluminatedwithotherfilters.Itsbrightnessmakesitidealforlowmagnificationquantificationstudies,whileitsuniqueexcitation/emissionprofileandmildstainingconditionsmakesitidealforcombinationformultipleimmunofluorescentlabelingstudies.Amylo-Glo®RTDiscompatIBLewithfresh,frozen,andformalin-fixedimmunohistochemistryorcytochemistry,anditisparticularlygoodforconfocalandmultiplelabelingbecauseofitshighfluorescentintensityandhighresistancetophoto-bleaching.MoreoverbecauseAmylo-Glo®fluorescesintheUVchannel,doubleandtriplelabelingexperimentscanbeperformedveryeasily(seeprotocol). |
Relatedproducts | TR-300-AG,MOAB-2antibody |
BatchNo. | seeproductlabel |
OtherNames | AmyloGlo |
CompoundName | Compound:Amylo-Glo;Classification:Styrylbenzenederivative;Appearance:Yellowsolution;MolecularWeight:392;Filtersystemforvisualizing:UVEthibiumBromide:EtBr,2,7-Diamino-10-ethyl-6-phenylphenanthridiniumbromide;Appearance:lightred-orangesolution;MolecularWeight:394.32.392;Filtersystemforvisualizing:UV |
Purity | Thinlayerchromatographyusingaluminaplatesandasolventsystemofethanolandwater(3:1)revealedthepresenceoftwofluorescentisomers.Noamountofstartingmaterialwasdetected. |
Biol.activity | ExcitationPeakforAmylo-Glo:334EmissionPeak:533nm-unbound,438nmwhenboundtoamyloid.EtBr:Ethidiumbromidehasanexcitationpeakof300nmandanemissionpeak595nm. |
Applications | Stainingofamyloidplaquesinhumanandanimaltissues,seeincludedprotocol.EtBrcounterstainstainsnucleiandcellbodiesforeasyidentificationandspacialorientation. |
Specificity | amyloidplaquesbothintraneuronalandvascularforA-G,Etbr,nucleiandcellbodiesbothDNAandRNAlabel |
Appearance | ExcitationPeak:334;EmissionPeak:533nm-unbound,438nmwhenboundtoamyloid.TovisualizeAmylo-glointissue,UVlightisrequired.Forexample,Amylo-GlotissuecanbeexaminedusinganepifluoresentmicroscopewithUV(NikonUV-2A)filtercube.Excitation(325-375nm)Emission(400-450nm)istypical.Alsonote,itisnotuncommonforAmylo-Glotoappearlightyellowwhenexaminedbyeye,yetappearalightbluecolorwhenphotographed. VisualizationofEtBr:Ethidiumbromidehasanexcitationpeakof300nmandanemissionpeak595nm.MostUVcompatiblefiltersetscanbeused. |
Reconstitution | Readytodiluteperprotocol10Xsolutions |
Storage | Thestocksolutioncanbestoredforupto6monthsat4°Cprotectedfromlight.Nopreservatives.Usesteriletechniquewhenhandlingandproperlaboratoryprocedures. |
ExpiryDate | 6monthsfromdateofpurchase |
GeneralReferences | L.Schmuedetal.(2012)J.NeuroscienceMethods209:120126 |
KitComponents | 1bottlecontaining40mlof10XAmylo-Glo®RTD(A-GRTD)solution1bottlecontaining40mlof10XA-GRTDEthidiumBromide(EtBrRTD)solution |
ReagentKitprotocol | TR-400-AG_as_at_Apr2014_protocol.pdf |
MSDS | MSDS_TR-400-AG_as_at_July2015.pdf |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。